Works matching IS 25233548 AND DT 2023 AND VI 43 AND IP 2

Results: 11

Criteria and regulatory considerations for the conditional approval of innovative antitumor drugs in China: from the perspective of clinical reviewers.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 171, doi. 10.1002/cac2.12400

By:

Zou, Limin;
Qi, Yueli;
Jiang, Yongling;
Tang, Ling;
Du, Yu;
Zhao, Boyuan;
Sun, Yanzhe;
Xiang, Meiyi;
Ma, Jun;
Yang, Zhimin

Publication type:

Article

Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 257, doi. 10.1002/cac2.12399

By:

Lin, Qing;
Zheng, Shangyou;
Yu, Xianjun;
Chen, Meifu;
Zhou, Yu;
Zhou, Quanbo;
Hu, Chonghui;
Gu, Jing;
Xu, Zhongdong;
Wang, Lin;
Liu, Yimin;
Liu, Qingyu;
Wang, Min;
Li, Guolin;
Cheng, He;
Zhou, Dongkai;
Liu, Guodong;
Fu, Zhiqiang;
Long, Yu;
Li, Yixiong

Publication type:

Article

Validation of different personalized risk models of chemotherapy‐induced nausea and vomiting: results of a randomized, double‐blind, phase III trial of fosaprepitant for cancer patients treated with high‐dose cisplatin.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 246, doi. 10.1002/cac2.12397

By:

Zhao, Yuanyuan;
Zhao, Bing;
Chen, Gang;
Chen, Yinlan;
Liao, Zijun;
Zhang, Haiming;
Feng, Weineng;
Li, Yinyin;
Weng, Heng;
Li, Weidong;
Zhou, Yuefen;
Ren, Biyong;
Lu, Yanda;
Chen, Jianhua;
Liu, Zhenteng;
Su, Zhenzhong;
Wang, Wenliang;
Zhang, Li

Publication type:

Article

Comparative risk of acute kidney injury among cancer patients treated with immune checkpoint inhibitors.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 214, doi. 10.1002/cac2.12396

By:

Liu, Fei;
Wang, Zixian;
Li, Xiaofan;
Zhang, Zhen;
Yang, Yue;
Chen, Junquan;
Chen, Dinghua;
Wu, Lingling;
Liu, Xiangyu;
Han, Sujun;
Wang, Fangming;
Wahafu, Wasilijiang;
Gao, Yibo;
Ren, Shancheng;
Xing, Nianzeng;
Cai, Guangyan;
Chen, Xiangmei

Publication type:

Article

Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 177, doi. 10.1002/cac2.12394

By:

Ghaedrahmati, Farhoodeh;
Esmaeil, Nafiseh;
Abbaspour, Maryam

Publication type:

Article

Elevated neutrophil extracellular traps by HBV‐mediated S100A9‐TLR4/RAGE‐ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 225, doi. 10.1002/cac2.12388

By:

Zhan, Xi;
Wu, Rui;
Kong, Xue‐Hua;
You, Yan;
He, Kun;
Sun, Xiao‐Yu;
Huang, Yong;
Chen, Wei‐Xian;
Duan, Liang

Publication type:

Article

Detection of piRNA‐54265 in human serum: evidence and significance.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 276, doi. 10.1002/cac2.12381

By:

Mai, Dongmei;
Ye, Ying;
Zhuang, Lisha;
Zheng, Jian;
Lin, Dongxin

Publication type:

Article

Social‐epigenetic mediators for racial disparities in pulmonary impairment among childhood cancer survivors.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 290, doi. 10.1002/cac2.12371

By:

Song, Nan;
Dong, Qian;
Chen, Cheng;
Li, Qian;
Mulder, Heather;
Plyler, Emily;
Easton, John;
Walker, Emily;
Olson, Scott;
Neale, Geoffrey;
Krull, Kevin R.;
Srivastava, Deo Kumar;
Ness, Kirsten K.;
Zhang, Jinghui;
Hudson, Melissa M.;
Robison, Leslie L.;
Huang, I‐Chan;
Wang, Zhaoming

Publication type:

Article

Malignant transformation by oncogenic K‐ras requires IDH2‐mediated reductive carboxylation to promote glutamine utilization.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 285, doi. 10.1002/cac2.12369

By:

Liu, Rui;
Liu, Panpan;
Bi, Huichang;
Ling, Jianhua;
Zhang, Huiqin;
Zhang, Mingquan;
Hu, Yumin;
Chiao, Paul J;
Huang, Peng;
Liu, Jinyun

Publication type:

Article

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors.

Published in:

Cancer Communications, 2023, v. 43, n. 2, p. 280, doi. 10.1002/cac2.12368

By:

Chen, Zhiwei;
Zhu, Peng;
Liu, Zuojin;
Zhu, Bin;
Yin, Guobing;
Ming, Jia;
Song, Rui;
Pan, Qingbo;
Li, Tong;
Jiang, Xingwei;
Wang, Bing;
Liu, Shuaibin;
Cai, Hongxing;
Wang, Jingjie;
Han, Yuling;
Lin, Zijing;
Hong, Yang;
Chen, Min;
Peng, Mingli;
Hu, Lina

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2023, v. 43, n. 2, p. 169, doi. 10.1002/cac2.12299
Publication type:: Article